Drug
-
California-based biopharmaceutical company Rubedo Life Sciences has announced that thanks to US$40 million in financial backing, it can commence human trials of its drug RLS-1469, designed to target the senescent cells that cause age-related disease.
-
A new drug for severe influenza successfully keeps patients at the perfect level of lung inflammation to protect against lung damage while still allowing the immune system to fight off the infection. It's effective in mice even days after infection.
-
Amid ongoing global shortages of semaglutide, the active ingredient in medical sensations Ozempic and Wegovy, researchers have uncovered a way to make 10 times more of the stuff, producing a therapeutically similar version of the in-demand drug.
-
A study has found that a compound created by the body’s breakdown of a cancer drug has therapeutic properties that could be used in combination with the original drug to boost prostate cancer treatment or as a novel treatment for Parkinson's disease.
-
A series of Phase 3 clinical trials into a novel oral, non-opioid painkiller has found that it’s effective in treating acute pain in both surgical and non-surgical settings. The drug's manufacturers plan to seek FDA approval in mid-2024.
-
White blood cell numbers can be cut by health conditions or treatments like chemotherapy. Yale scientists have now discovered a molecule that can be given to quickly boost their numbers back up, to help fight off infections without antibiotics.
-
No matter how important something is, too much of anything is bad for you. Scientists have now put that principle to work to kill cancer, with a new drug that causes calcium to build up and choke the tumor to death.
-
Researchers have created a ‘two-headed’ drug that prevents the production of the toxic protein linked to Parkinson’s disease before destroying the RNA machinery that makes it. The drug may be a way of slowing or even stopping the disease’s progression.
-
Antibiotic-resistant bacteria are poised to become a global health concern. In the race to develop new weapons, scientists have created a new family of antibacterial polymers that can kill 'superbugs' in a way they can't evolve resistance to.
-
An effective single-dose, long-term treatment for anxiety could be within reach, with the phase 2b clinical trial of MM-120 reported to have passed the stage with flying colors.
-
A world-first clinical trial has found that a drug commonly prescribed for rheumatoid arthritis preserved the pancreatic cells’ ability to produce insulin and slowed the progression of type 1 diabetes in those recently diagnosed with the condition.
-
Managing diabetes usually involves regular shots, but soon patients might only need injections a few times a year. Stanford has developed a hydrogel-based delivery system that slowly releases drugs over months to control diabetes and even weight.
Load More